The relationship between gait task performance and AD plasma biomarkers in cognitively unimpaired older adults and patients with mild cognitive impairment

Abstract

Background: Gait impairments in Alzheimer’s disease (AD) and related dementias pose a major fall risk/contribute to morbidity/mortality. The Timed Up and Go (TUG) test is often used to assess mobility, gait changes, and dual‐task performance.